Thu, Jan 18, 2024
On Thursday, Sun Pharma shares ended weaker by Rs 14.3, or 1.1 per cent, at Rs 1,299.3 apiece.
More >
Wed, Jan 17, 2024
Under the terms of the agreement, Bayer has granted non-exclusive rights to Sun Pharma to market and distribute a second Finerenone product under the brand name Lyvelsa. Finerenone was first launched by Bayer under the brand name Kerendia in 2022.
Wed, Jan 03, 2024
Sun Pharma hits a new high after acquiring Israel's Libra Merger, consolidating its presence in the region. This follows a recent US investment in Lyndra Therapeutics. We break down the deals and their potential impact on Sun Pharma's future.
Fri, Dec 09, 2022
Sun Pharma share price: Stocks of Sun Pharmaceutical Industries Limited, NSE: SUNPHARMA traded flat in early morning deals on Friday.
Thu, Dec 08, 2022
Markets are seeing time-wise correction and weak global cues are delaying the recovery, Ajit Mishra, VP - Technical Research, Religare Broking.
The 30-share index gained 160 points to settle at 62,570.68 as 13 of its components advanced while 17 declined.
Sunpharma share price, NSE: SUNPHARMA: Shares of Sun Pharmaceutical Industries Ltd fell more than 3 per cent after United States Food and Drug Administration (USFDA) put its Halol, Gujarat facility under import alert.
Mon, Nov 21, 2022
Indian automotive manufacturer Tata Motors will replace pharmaceutical company Dr Reddy’s Laboratories in the 30-share benchmark S&P BSE Sensex effective December 19, 2022.
Wed, Nov 02, 2022
Except for Nifty Metal, Pharma, and Media almost all sectoral indices closed negative. Nifty Auto, IT and Banks dragged the frontline indices most during today’s session.
Indian equity markets ended on a negative note on Wednesday, breaking a four-day gaining streak. The stock markets traded in a narrow range today after opening in the green only to take a U-turn, minutes later.
Sun Pharma share price: Post second quarter results, brokerages have revised the target price on the stock
Traders Diary: In today's edition of traders diary, Zee Business reserach team brings an exclusive research on 20 stocks where investors could look to make strategies to maximise their gains or avert losses
Mon, Oct 31, 2022
As per Zee Business estimates, the company’s revenue may come at Rs 10,808 crore, and profit after tax at Rs 1.964.7 crore, while EBITDA is likely to be at Rs 2781.7 crore and, margins around 25.7 per cent in Q2.
Mon, Oct 03, 2022
In contrast to the benchmark indices, the pharma and healthcare indices surged in a weak market.
Thu, Sep 29, 2022
The stock in the last two sessions has gained nearly 7% on account of the acquisition announcement of Uractiv portfolio from Fiterman Pharma in Romania
The stock in the last two sessions has gained nearly 7 per cent on account of the acquisition announcement of Uractiv portfolio from Fiterman Pharma in Romania.
Sat, Sep 03, 2022
Stocks to Buy: From pharmaceutical to information and technology, domestic brokerage from Centrum Broking comes out with the top five large-cap company stocks with high conviction to buy in September for an upside of up to 44 per cent on a long-term basis.
Mon, Aug 01, 2022
Despite healthy Q1FY23 earnings, the pharma major Sun Pharma shares were seen trading flat in the early morning and later declined more than 3 per cent to Rs 913 per share on the BSE intraday on Monday.
Mon, Jul 25, 2022
Life Insurance Corporation on Monday said it has reduced shareholding in Sun Pharmaceuticals by selling 2 per cent stake in the company for about Rs 3,882 crore
Fri, Jul 22, 2022
Global Brokerage report on pharma stocks of this week. In this video know the full list and target price to make a buy choice.
Mon, Jun 06, 2022
Drug major Sun Pharma plans to increase its field force in the domestic market by 10 per cent in the current fiscal in order to drive twin objectives of brand focus and geographical expansion, according to a senior company official.
Tue, May 31, 2022
Indian markets on Tuesday witnessed a gap-down opening as Sensex slumped over 300 points and Nifty above 16600 levels. Almost all indices were in red with Nifty IT and FMCG being the top losers.
Sun, May 22, 2022
The drug is used to treat depression and prevent Seasonal Affective Disorder (SAD). It is also used to help people stop smoking.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
